{
    "accession": "ENCBS679QAH",
    "age": "35",
    "age_units": "year",
    "applied_modifications": [],
    "biosample_term_id": "NTR:0000634",
    "biosample_term_name": "activated T-helper 2 cell",
    "biosample_type": "primary cell",
    "characterizations": [],
    "dbxrefs": [],
    "description": "",
    "documents": [
        {
            "attachment": "/documents/f1b60b4e-b5d2-4b8d-af0b-06b767fa07c3/@@download/attachment/ENCODE-Protocol%2006.25.20-Unutmaz-update.pdf",
            "document_type": "cell isolation protocol",
            "references": [],
            "urls": []
        }
    ],
    "donor": "ENCDO374BBL",
    "lab": "Charles Lee",
    "life_stage": "adult",
    "organism": "Homo sapiens",
    "references": [],
    "sex": "male",
    "source": "AllCells",
    "summary": "Homo sapiens male adult (35 years) activated T-helper 2 primary cell treated with 5 \u03bcg/mL Interferon-gamma antibody, 100 ng/mL Interleukin-4, anti-CD3 and anti-CD28 coated beads",
    "treatments": [
        {
            "dbxrefs": [],
            "treatment_term_name": "Interferon-gamma antibody",
            "treatment_type": "antibody"
        },
        {
            "dbxrefs": [],
            "treatment_term_id": "UniProtKB:P05112",
            "treatment_term_name": "Interleukin-4",
            "treatment_type": "protein"
        },
        {
            "dbxrefs": [],
            "treatment_term_name": "anti-CD3 and anti-CD28 coated beads",
            "treatment_type": "antibody"
        }
    ]
}